Trade ATAI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AtaiBeckley Inc. (ATAI) is trading at US$7.35, up 0.00% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.74B. Over the past 52 weeks, ATAI has traded between US$3.27 and US$7.45. On Syfe you can trade ATAI with $0 commission and add it to your watchlist.
| Previous close | US$7.35 |
|---|---|
| Market cap | US$2.74B |
| 52-week range | US$3.27 – US$7.45 |
| Volume | 9.59M |
| Exchange | US |
Add to Watchlist
Set Price Alert
AtaiBeckley Inc.
Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.
Year: 2021
Oppenheimer Downgrades AtaiBeckley to Market Perform From Outperform
Aug 17, 6:59 PM · MT Newswires
Deutsche Bank Downgrades AtaiBeckley to Hold From Buy, Adjusts PT to $8 From $12
Aug 12, 11:11 AM · MT Newswires
TD Cowen Downgrades AtaiBeckley to Hold From Buy
Jul 20, 11:18 AM · MT Newswires
AtaiBeckley Inc. (ATAI) stock is trading at US$7.35, 0.00% from the previous close of US$7.35.
The market cap for AtaiBeckley Inc. (ATAI) stock is approximately US$2.74B.
The 52-week high for AtaiBeckley Inc. (ATAI) stock is US$7.45.
The 52-week low for AtaiBeckley Inc. (ATAI) stock is US$3.27.
AtaiBeckley Inc. (ATAI) does not currently pay a dividend.
Stay on top of ATAI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
